Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
Go back to Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026| (NASDAQ: CMPX) | Delayed: 2.07 -0.05 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.12 | 52 Week High | $ | |||
| Open | $2.12 | 52 Week Low | $ | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $2.06 | EPS | $ | |||
| Volume | 1,589,938 | |||||
